The best peptide APIs manufacturer
GMP peptide, peptide product, peptide, peptide research,polypeptide APIs,china peptide company,peptid list

Chengdu shengnuo biopharmaceutical Co., Ltd., subordinate to Chengdu Shengnuo Biotechnology Co., Ltd., is located in Dayi County, Chengdu City, the land of abundance, with a registered capital of 50 million yuan. It is a professional enterprise engaged in product development, technical services, large-scale production and export of peptide drugs.

Atosiban acetate GMP certificate

![Atosiban acetate GMP certificate](C:\Users\leilimei\Desktop\Atosiban acetate GMP certificate.jpg)

Certificate of somatostatin, thymus pentapeptide, octreotide acetate GMP

![GMP certificate of carbamazine](C:\Users\leilimei\Desktop\GMP certificate of carbamazine.jpg)

GMP certificate of enfovir peptide API

![GMP certificate of enfovir peptide API](C:\Users\leilimei\Desktop\GMP certificate of enfovir peptide API.jpg)

GMP certificate of freeze-dried powder injection

![GMP certificate of freeze-dried powder injection](C:\Users\leilimei\Desktop\GMP certificate of freeze-dried powder injection.jpg)

Left west montane GMP certificate

![Left west montane GMP certificate](C:\Users\leilimei\Desktop\Left west montane GMP certificate.jpg)

Mexico GMP certificate of leosimendan and enfovir peptide

![Mexico GMP certificate of leosimendan and enfovir peptide (2)](C:\Users\leilimei\Desktop\Mexico GMP certificate of leosimendan and enfovir peptide (2).jpg)

New GMP certificate for thymus method

![New GMP certificate for thymus method](C:\Users\leilimei\Desktop\New GMP certificate for thymus method.jpg)

Small volume injection (non-final sterilization)

![Small volume injection (non-final sterilization)](C:\Users\leilimei\Desktop\Small volume injection (non-final sterilization).jpg)

The company has "Sichuan peptide drug engineering technology research center", which is a high-tech enterprise in Chengdu and Sichuan Province. The enterprise has participated in the key technology research of peptide chemical modification and industrial scale preparation, a major new drug creation project of the 11th Five Year Plan of China. In 2010, it was supported by the special fund of Sichuan Provincial Economic Commission for emerging industries to carry out the research on the industrialization achievement transformation of peptide drugs.

All the above projects have completed the project construction. At present, the company has more than 50 key technologies of peptide drugs and products on the market at home and abroad, and the single batch output can reach kg level; it has international leading technologies such as large-scale production technology of thiocyclopeptide, large-scale production technology of carbocyclopeptide, complex peptide technology, rapid peptide synthesis technology, etc.; it has applied for 23 invention patents, has obtained 5 invention patent authorizations, with its excellent many The key technology of peptide synthesis, modification and purification has become the leader of peptide industry in China.

Mr. Wen Yongjun, the founder of the company, is the originator of Hainan Zhonghe thymopentin (and Japan), the first polypeptide drug listed in China, and thymopentin α 1 with a single product sales revenue of more than 500 million, and the leader of the R & D and production team of stable polypeptide drugs.

The company attaches great importance to the combination of learning and research, and has formed a close strategic partnership with scientific research institutions such as Sichuan University, Lanzhou University, Jilin University, Academy of Military Sciences, organic Institute of Chinese Academy of Sciences, Provincial Institute of drug control, etc. The company cooperates closely with foreign pharmaceutical peptide manufacturers in the same industry.

It cooperates with a peptide manufacturer in India and provides training and production guidance to employees of Indian factories. All the technologies used are owned by the company. It keeps in touch with and exchanges with internationally renowned peptide technology research units to study the structure and function of biotechnology drugs from multiple perspectives and in-depth, so as to further apply them to We should actually accumulate scientific data and lay a solid foundation.

With the support of governments at all levels and after years of efforts, Suntory has the conditions for peptide drug research and industrialization, and will strive to achieve the goal of becoming the largest peptide drug production base in China.

Since 2007, the company has passed many CFDA certification inspections in China, and since 2012, it has passed the FDA on-site inspection and certification in the United States with zero defects. After that, the company has received three FDA on-site inspections in the United States and the official coffepris in Mexico Three on-site inspections and on-site certification inspections of South Korean official MFDs, as well as many on-site audit inspections of famous large companies such as the United States, South Korea, Mexico and India every year, have passed various official and customer certification inspections with good production quality management status. The production quality management system of the company is strictly managed and implemented in accordance with the GMP regulations of China and relevant countries. Many polypeptide products of the company are exported to the United States, Europe, Mexico, South Korea, India and other countries with the increasing export trend year by year. The high-quality products have won good brand effect.

Shengnuo bio PRODUCT

Atosiban Acetate Injection Carbetocin Injection OctreotideAcetate Injection Enfuvirtide for injection
Thymus for injection is new Thymopentin for Injection Levosimendan Injection Atosiban Acetate Injection

INQUIRE

NAME:

EMAIL:

MASSAGE:


Best sales manager contact

Contacts Roleagh
Tel 86-28-88203630
Fax 86-28-88203630
Email roleagh@gmail.com
QQ 2539328606
Facebook LEI LI

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.

Load more